RE:RE:RE:RE:RE:RE:RE:13 G filingWhile it is always hard to understand Soleus' filings because of how they treat the warrants, it appears they have added to their postion and that was the reason for their filing. It is separate from the 7.5 million share block trade which may be related to intercompany accoutning moves at Morgan Stanley? If so, that indicates they may ahve bought more shares too since they did not own 7.5 million shares as of 6/30.
qwerty22 wrote: "The shares of common stock reported in this row are held by Soleus Capital Master Fund, L.P. (“Master Fund”), and include a presently exercisable warrant to purchase up to 1,550,000 shares of common stock at an exercise price of $3.14 per share (the “Warrant”). Soleus Capital, LLC is the sole general partner of Master Fund and thus holds voting and dispositive power over the shares held by Master Fund. "
So for people that don't understand these types of transactions, like me, why would Soleus do this?
palinc2000 wrote:
https://www.theratech.com/static-files/446de95b-5b8e-4464-9058-dd6bbd822fc7
SPCEO1 wrote: I cannot find that filing - where did you see it? Is it from today?
palinc2000 wrote:
My understsnfing is that the Filing is simply to account for the transfer of the shsres ftom Soleus to a General Partner controlled by Soleus
palinc2000 wrote: [The 9.5 mil'ion includes
1555000 warrabts
quote=palinc2000]
Seems like Soleus hold 9.5 million shares representing 10.1 %
palinc2000 wrote: Soleus
[/quote]